Hellman Jordan Management CO Inc Novavax Inc Transaction History

Hellman Jordan Management CO Inc

  • $58.9 Million
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 06, 2021
SELL
$112.98 - $319.93 $1.13 Million - $3.2 Million
-10,000 Closed
0 $0
Q4 2020

Jan 29, 2021
SELL
$78.74 - $139.5 $3.22 Million - $5.71 Million
-40,910 Reduced 80.36%
10,000 $1.12 Million
Q3 2020

Nov 12, 2020
BUY
$79.44 - $178.51 $4.04 Million - $9.09 Million
50,910 New
50,910 $5.52 Million

Others Institutions Holding NVAX

# of Institutions
292
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $629M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Hellman Jordan Management CO Inc Portfolio

Follow Hellman Jordan Management CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hellman Jordan Management CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Hellman Jordan Management CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email